Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Core EBITDA Growth

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 27.2537.67-7.1420.1417.54

What is the latest Core EBITDA Growth ratio of MANKIND PHARMA ?

The latest Core EBITDA Growth ratio of MANKIND PHARMA is 27.25 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202527.25
Mar202437.67
Mar2023-7.14
Mar202220.14
Mar202117.54

How is Core EBITDA Growth of MANKIND PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 27.25
-27.66
Mar2024 37.67
Positive
Mar2023 -7.14
Negative
Mar2022 20.14
14.82
Mar2021 17.54 -

Other Financial Ratios of MANKIND PHARMA


Compare Core EBITDA Growth ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹93,429.0 Cr -5% -8.8% -14.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,147.0 Cr 0.2% 2.3% -9.3% Stock Analytics
DIVIS LABORATORIES ₹176,708.0 Cr -1.3% 9.1% 16.7% Stock Analytics
CIPLA ₹121,525.0 Cr 0.2% -0.6% -3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,147.0 Cr 0.6% 1% 10.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,596.0 Cr 0.6% -3.5% -4.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5%

-8.8%

-14.2%

SENSEX

-1.4%

1.7%

4.8%


You may also like the below Video Courses